Ghrelin and obestatin in thyroid dysfunction

Endokrynologia Polska

Volumn 63, Issue 6, 2012, Pages 456-462

  Gurgul, Edyta ^a   Ruchała, Marek ^a   Kosowicz, Jerzy ^a   Zamysłowska, Hanna ^a   Wrotkowska, Elzbieta ^a   Moczko, Jerzy ^a   Sowiński, Jerzy ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Ghrelin; Hyperthyroidism; Hypothyroidism; Obestatin; Thyroid

Indexed keywords

GHRELIN; LEVOTHYROXINE; LIOTHYRONINE; OBESTATIN; THYROID HORMONE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CORRELATIONAL STUDY; DRUG WITHDRAWAL; FEMALE; HASHIMOTO DISEASE; HORMONE BLOOD LEVEL; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; LIOTHYRONINE BLOOD LEVEL; MALE; POSTOPERATIVE COMPLICATION; THYROIDITIS; THYROXINE BLOOD LEVEL; TREATMENT WITHDRAWAL;

ADULT; CASE-CONTROL STUDIES; FEMALE; GHRELIN; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; MALE; MIDDLE AGED; THYROIDECTOMY; THYROXINE;

EID: 84876176890     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Kojima M, Hosoda AH, Date Y, Nakazato M et al. Ghrelin is a growth hormone releasing acylated peptide from stomach. Nature 1999; 402: 656-660.
2. Zhang JV, Ren P, Avsian-Kretchmer O et al. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 2005; 310: 996-999.
3. Soares JB, Leite-Moreira AF. Ghrelin, des-acyl ghrelin and obestatin: Three pieces of the same puzzle. Peptides 2008; 29: 1255-1270.
4. Takaya K, Ariyasu H, Kanamoto N et al. Ghrelin strongly stimulates growth hormone release in humans. J Clin Endocrinol Metab 2000; 85: 4908-4911.
5. Wren AM, Seal LJ, Cohen MA et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2001; 86: 5992.
6. Chen HY, Trumbauer ME, Chen AS et al. Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein. Endocrinology 2004; 145: 2607-2612.
7. Kim MS, Yoon CY, Jang PG et al. The mitogenic and antiapoptotic actions of ghrelin in 3T3-L1 adipocytes. Mol Endocrinol 2004; 18: 2291-2301.
8. Dornonville de la Cour C, Lindström E, Norlén P et al. Ghrelin stimulates gastric emptying but is without effect on acid secretion and gastric endocrine cells. Regul Pept 2004; 120: 23-32.
9. Tack J, Depoortere I, Bisschops R et al. Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis. Aliment Pharmacol Ther 2005; 22: 847-853.
10. Yasuda T, Masaki T, Kakuma T et al. Centrally administered ghrelin suppresses sympathetic nerve activity in brown adipose tissue of rats. Neurosci Lett 2003; 349: 75-78.
11. Hosoda H, Kojima M, Mizushima T et al. Structural divergence of human ghrelin. Identification of multiple ghrelin-derived molecules produced by post-translational processing. J Biol Chem 2003; 278: 64-70.
12. Ariyasu H, Takaya K, Tagami T et al. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab 2001; 86: 4753-4758.
13. Gnanapavan S, Kola B, Bustin SA et al. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 2002; 87: 2988-2991.
14. Raghay K, Garcia-Caballero T, Nogueiras R et al. Ghrelin localization in rat and human thyroid and parathyroid glands and tumors. Histochem Cell Biol 2006; 89: 400-409.
15. Karaoglu A, Aydin S, Dagli AF et al. Expression of obestatin and ghrelin in papillary thyroid carcinoma. Mol Cell Biochem 2009; 323: 113-118.
16. Ueberberg B, Unger N, Saeger W, Mann K, Petersenn S. Expression of ghrelin and its receptor in human tissues. Horm Metab Res 2009; 41: 814-821.
17. Cassoni P, Papotti M, Catapano F et al. Specific binding sites for synthetic growth hormone secretagogues in non-tumoral and neoplastic human thyroid tissue. J Endocrinol 2000; 165: 139-146.
18. Papotti M, Ghe C, Cassoni P et al. Growth hormone secretagog binding sites in peripheral human tissues. J Clin Endocrinol Metab 2000; 85: 3803-3807.
19. Cummings DE. Ghrelin and the short- and long-term regulation of appetite and body weight. Physiol Behav 2006; 89: 71-84.
20. Williams DL, Cummings DE. Regulation of ghrelin in physiologic and pathophysiologic states. J Nutr 2005; 135: 1320-1325.
21. Tanaka M, Naruo T, Muranaga T et al. Increased fasting plasma ghrelin levels in patients with bulimia nervosa. Eur J Endocrinol 2002; 146: R1-3.
22. Tanaka M, Naruo T, Yasuhara D et al. Fasting plasma ghrelin levels in subtypes of anorexia nervosa. Psychoneuroendocrinology 2003; 28: 829-835.
23. Garcia JM, Garcia-Touza M, Hijazi RA et al. Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia. J Clin Endocrinol Metab 2005; 90: 2920-2926.
24. Zhao CM, Furnes MW, Stenström B et al. Characterization of obestatinand ghrelin-producing cells in the gastrointestinal tract and pancreas of rats: an immunohistochemical and electron-microscopic study. Cell Tissue Res 2008; 331: 575-587.
25. Grönberg M, Tsolakis AV, Magnusson L et al. Distribution of obestatin and ghrelin in human tissues: immunoreactive cells in the gastrointestinal tract, pancreas and mammary glands. J Histochem Cytochem 2008; 56: 793-801.
26. Volante M, Rosas R, Ceppi P et al. Obestatin in human neuroendocrine tissues and tumours: expression and effect on tumour growth. J Pathol 2009; 218: 458-466.
27. Bresciani E, Rapetti D, Dona F et al. Obestatin inhibits feeding but does not modulate GH and corticosterone secretion in the rat. J Endocrinol Invest 2006; 29: RC 16-18.
28. Gourcerol G, St-Pierre DH, Taché Y. Lack of obestatin effects on food intake - should obestatin be renamed ghrelin-associated peptide (GAP)? Regul Pept 2007; 141: 1-7.
29. Lagaud GJ, Young A, Acena A et al. Obestatin reduces food intake and suppresses body weight gain in rodents. Biophys Res Commun 2007; 357: 264-269.
30. Holst B, Egerod KL, Schild E et al. GPR39 signaling is stimulated by zinc ions but not by obestatin. Endocrinology 2007; 148: 13-20.
31. Nakahara T, Harada T, Yasuhara D et al. Plasma obestatin concentrations are negatively correlated with body mass index, insulin resistance index, and plasma leptin concentrations in obesity and anorexia nervosa. Biol Psychiatry 2008; 64: 252-255.
32. Beasley JM, Ange BA, Anderson CAM et al. Characteristics associated with fasting hormones (obestatin, ghrelin and leptin). Obesity 2009; 17: 349-354.
33. Ruchała M, Rafińska L, Kosowicz J et al. The analysis of exogenous ghrelin plasma activity and tissue distribution. Neuro Endocrinol Lett 2012; 33: 191-195.
34. Braclik M, Marcisz C, Giebel S et al. Serum leptin and ghrelin levels in premenopausal women with stable body mass index during treatment of thyroid dysfunction. Thyroid 2008; 18: 545-550.
35. Gjedde S, Vestergaard E, Gormsen LC et al. Serum ghrelin levels are increased in hypothyroid patients and become normalized by L-thyroxine treatment. J Clin Endocrinol Metab 2008; 93: 2277-2280.
36. Kosowicz J, Baumann-Antczak A, Ruchala M et al. Thyroid hormones affect plasma ghrelin and obestatin levels. Horm Metab Res 2010; 43: 121-125.
37. Giménez-Palop O, Giménez-Pérez G, Mauricio D et al. Circulating ghrelin in thyroid dysfunction is related to insulin resistance and not to hunger, food intake or anthropometric changes. Eur J Endocrinol 2005; 153: 73-79.
38. Tanda ML, Lombardi V, Genovesi M et al. Plasma total and acylated ghrelin concentrations in patients with clinical and subclinical thyroid dysfunction. J Endocrinol Invest 2009; 32: 74-78.
39. Sadegholvad A, Afkhamizadeh M, Ranjbar-Omrani G. Serum ghrelin changes in thyroid dysfunction. Arch Iran Med 2007; 10: 168-170.
40. Bergmann T, Kuwert T, Lohmann T et al. No association between thyroid function and peripheral leptin, ghrelin or adiponectin levels. Exp Clin Endocrinol Diabetes 2004; 112-P103.
41. Bergmann T, Lohmann T, Wallaschofski H. Association between thyroid function and ghrelin or adiponectin levels. Exp Clin Endocrinol Diabetes 2003; 111: 395-396.
42. Altinova AE, Törüner FB, Karakoc A et al. Serum ghrelin levels in patients with Hashimoto's thyroiditis. Thyroid 2006a; 16: 1259-1264.
43. Riis AL, Hansen TK, Moller N et al. Hyperthyroidism is associated with suppressed circulating ghrelin level. J Clin Endocrinol Metab 2003; 88: 853-857.
44. Rojdmark S, Calissendorff J, Danielsson O et al. Hunger-satiety signals in patients with Graves' thyrotoxicosis before, during, and after long-term pharmacological treatment. Endocrine 2005; 27: 55-61.
45. Altinova AE, Törüner FB, Aktürk M et al. Reduced serum acylated ghrelin levels in patients with hyperthyroidism. Horm Res 2006b; 65: 295-299.
46. Theodoropoulou A, Psyrogiannis A, Metallinos IC et al. Ghrelin response to oral glucose load in hyperthyroidism, before and after treatment with antithyroid drugs. Endocrinol Invest 2009; 32: 94-97.
47. El Gawad SS, El-Kenawy F, Mousa AA et al. Plasma levels of resistin and ghrelin before and after treatment in patients with hyperthyroidism. Endocr Pract 2012; 18: 376-381.
48. Kosowicz J, Baumann-Antczak A et al. Technological difficulties in ghrelin and obestatin assays. Endokrynol Pol 2011; 62: 336-339.
49. Douyon L, Schteingart DE. Effect of obesity and starvation on thyroid hormone, growth hormone, and cortisol secretion. Endcrinol Metab Clin North Am 2002; 31: 173-189.
50. Kluge M, Riedl S, Uhr M et al. Ghrelin affects the hypothalamuspituitary- thyroid (HPT) axis in humans by increasing free thyroxine (fT4) and decreasing TSH in plasma. Eur J Endocrinol 2010; 162: 1059-1065.
51. Mariani LH, Berns JS. The renal manifestations of thyroid disease. J Am Soc Nephrol 2012; 23: 22-26.
52. De Vriese C, Hacquebard M, Gregoire F et al. Ghrelin interacts with human plasma lipoproteins. Endocrinology 2007; 148: 2355-2362.
53. Zizzari P, Longchamps R, Epelbaum J et al. Obestatin partially affects ghrelin stimulation of food intake and growth hormone secretion in rodents. Endocrinology 2007; 148: 1648-1653.
54. Seim I, Herington AC, Chopin LK. New insights into the molecular complexity of the ghrelin gene locus. Cytokine Growth Factor Rev 2009; 20: 297-304.